← Open Payments lookup

GAGANDEEP KAUR: Open Payments

NPI 1639734700 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$437 in 18 payments from 11 companies in 2025. Trend: 2023 $450 · 2024 $0 · 2025 $437

Food & beverage: $437
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$121
ABBVIE INC.3$66
Lundbeck LLC2$46
Vanda Pharmaceuticals Inc.1$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$31
Novo Nordisk Inc1$31
Exact Sciences Corporation1$26
Otsuka America Pharmaceutical, Inc.1$25
GlaxoSmithKline, LLC.1$20
PFIZER INC.1$19

Products named: CAPLYTA, REXULTI, QULIPTA, HETLIOZ, XIFAXAN, Wegovy, VRAYLAR, Cologuard Collection Kit.

Industry payments across CA — which companies pay providers there.